Bigul

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
10-04-2023
Bigul

NOVARTIS INDIA LTD. - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Intimation of Newspaper Advertisement by Novartis India Limited regarding the Notice of meeting of the Board of Directors of the Company
01-04-2023
Bigul

NOVARTIS INDIA LTD. - 500672 - Closure of Trading Window

Closure of Trading Window
31-03-2023
Bigul

NOVARTIS INDIA LTD. - 500672 - Board Meeting Intimation for Intimation Of Meeting Of The Board Of Directors Of Novartis India Limited And Closure Of Trading Window

NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2023 ,inter alia, to consider and approve the Audited Financial Results of the Company for the year ended March 31, 2023; and recommend dividend on equity shares of the Company, if any, for the financial year ended March 31, 2023
31-03-2023
Bigul

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
21-03-2023
Bigul

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
15-03-2023

Novartis launches new $11 billion share buyback

The Swiss company said it will buy a maximum of 10% of its own stock over the period from its last Annual General Meeting, which took place on March 7, up to the AGM in 2026.
13-03-2023
Bigul

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
10-03-2023
Bigul

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
08-03-2023
Next Page
Close

Let's Open Free Demat Account